Jianmin Pharmaceutical Group Co Ltd (600976) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jianmin Pharmaceutical Group Co Ltd (600976) has a cash flow conversion efficiency ratio of 0.039x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥106.82 Million ≈ $15.63 Million USD) by net assets (CN¥2.72 Billion ≈ $398.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Jianmin Pharmaceutical Group Co Ltd to measure how many days the company can operate on defensive assets alone.
Jianmin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Jianmin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jianmin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jianmin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hovnanian Enterprises Inc
NYSE:HOV
|
-0.081x |
|
Guangzhou Amsky Technology Co Ltd
SHE:300521
|
-0.033x |
|
Chongqing QinAn M&E PLC
SHG:603758
|
0.031x |
|
Tongyang Inc
KO:001525
|
-0.001x |
|
Shinkong Textile Co Ltd
TW:1419
|
0.015x |
|
EirGenix
TWO:6589
|
-0.020x |
|
APG SGA SA
SW:APGN
|
0.000x |
|
Mrs. Bectors Food Specialities Limited
NSE:BECTORFOOD
|
0.084x |
Annual Cash Flow Conversion Efficiency for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Jianmin Pharmaceutical Group Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.72 Billion ≈ $398.20 Million |
CN¥274.53 Million ≈ $40.17 Million |
0.101x | +5.52% |
| 2024-12-31 | CN¥2.45 Billion ≈ $358.56 Million |
CN¥234.27 Million ≈ $34.28 Million |
0.096x | -19.62% |
| 2023-12-31 | CN¥2.26 Billion ≈ $330.19 Million |
CN¥268.39 Million ≈ $39.27 Million |
0.119x | +2.92% |
| 2022-12-31 | CN¥1.87 Billion ≈ $273.32 Million |
CN¥215.87 Million ≈ $31.59 Million |
0.116x | -30.07% |
| 2021-12-31 | CN¥1.57 Billion ≈ $229.48 Million |
CN¥259.18 Million ≈ $37.93 Million |
0.165x | +74.20% |
| 2020-12-31 | CN¥1.32 Billion ≈ $193.63 Million |
CN¥125.54 Million ≈ $18.37 Million |
0.095x | +53.92% |
| 2019-12-31 | CN¥1.21 Billion ≈ $176.76 Million |
CN¥74.45 Million ≈ $10.89 Million |
0.062x | +10.97% |
| 2018-12-31 | CN¥1.15 Billion ≈ $167.56 Million |
CN¥63.60 Million ≈ $9.31 Million |
0.056x | +74.75% |
| 2017-12-31 | CN¥1.11 Billion ≈ $162.05 Million |
CN¥35.20 Million ≈ $5.15 Million |
0.032x | -71.21% |
| 2016-12-31 | CN¥1.03 Billion ≈ $150.92 Million |
CN¥113.84 Million ≈ $16.66 Million |
0.110x | +127.22% |
| 2015-12-31 | CN¥997.36 Million ≈ $145.94 Million |
CN¥48.45 Million ≈ $7.09 Million |
0.049x | -52.85% |
| 2014-12-31 | CN¥1.00 Billion ≈ $146.63 Million |
CN¥103.23 Million ≈ $15.11 Million |
0.103x | +113.60% |
| 2013-12-31 | CN¥940.46 Million ≈ $137.62 Million |
CN¥45.36 Million ≈ $6.64 Million |
0.048x | -55.63% |
| 2012-12-31 | CN¥903.10 Million ≈ $132.15 Million |
CN¥98.17 Million ≈ $14.37 Million |
0.109x | +226.20% |
| 2011-12-31 | CN¥876.97 Million ≈ $128.33 Million |
CN¥-75.54 Million ≈ $-11.05 Million |
-0.086x | -148.72% |
| 2010-12-31 | CN¥848.81 Million ≈ $124.21 Million |
CN¥150.08 Million ≈ $21.96 Million |
0.177x | +117.47% |
| 2009-12-31 | CN¥820.32 Million ≈ $120.04 Million |
CN¥66.69 Million ≈ $9.76 Million |
0.081x | -43.79% |
| 2008-12-31 | CN¥761.24 Million ≈ $111.39 Million |
CN¥110.11 Million ≈ $16.11 Million |
0.145x | +1660.69% |
| 2007-12-31 | CN¥742.63 Million ≈ $108.67 Million |
CN¥-6.88 Million ≈ $-1.01 Million |
-0.009x | -112.65% |
| 2006-12-31 | CN¥766.61 Million ≈ $112.18 Million |
CN¥56.18 Million ≈ $8.22 Million |
0.073x | +260.73% |
| 2005-12-31 | CN¥759.65 Million ≈ $111.16 Million |
CN¥-34.63 Million ≈ $-5.07 Million |
-0.046x | -877.87% |
| 2004-12-31 | CN¥705.12 Million ≈ $103.18 Million |
CN¥4.13 Million ≈ $604.74K |
0.006x | -59.37% |
| 2003-12-31 | CN¥290.32 Million ≈ $42.48 Million |
CN¥4.19 Million ≈ $612.80K |
0.014x | -- |
About Jianmin Pharmaceutical Group Co Ltd
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China.